首页> 外文期刊>Acta Haematologica >A case report of acute myeloid leukemia after liver transplantation
【24h】

A case report of acute myeloid leukemia after liver transplantation

机译:肝移植后急性髓细胞性白血病一例报告

获取原文
获取原文并翻译 | 示例
           

摘要

Acute myeloid leukemia (AML) is a rare complication observed after liver transplantation and only a handful of cases have been reported until now. We report a case of acute promyelocytic leukemia (APL) after liver transplantation in a 50-year-old man. The case presentation was postodontectomy bleeding with an associative abnormal coagulation test 85 months after liver transplantation. A routine blood test, bone marrow test, chromosome analysis and examination of PML/RARα chimeric gene confirmed the diagnosis of APL and disseminated intravascular coagulation (DIC). Induction chemotherapy with all-trans retinoic acid, arsenic trioxide and daunorubicin was given to this patient and complete remission was achieved. The patient was subjected to DA (daunorubicin combined with cytarabine) and MA (mitoxantrone combined with cytarabine) regimens after remission induction to consolidate the chemotherapy for two courses of treatment, and subsequently subjected to arsenous acid chemotherapy on a periodic basis. Twenty-two months into the follow-up, sustained bone marrow remission was observed with the adapted treatment regimen.
机译:肝移植后观察到急性髓细胞性白血病(AML)是一种罕见的并发症,迄今为止仅报告了少数病例。我们报告了一名50岁男子肝移植后急性早幼粒细胞白血病(APL)的病例。病例报告是牙移植术后出血,伴有肝移植后85个月的异常凝血试验。常规血液检查,骨髓检查,染色体分析和PML /RARα嵌合基因检查证实了APL和弥散性血管内凝血(DIC)的诊断。该患者接受全反式维甲酸,三氧化二砷和柔红霉素的诱导化疗,并完全缓解。缓解诱导后,患者接受DA(柔红霉素联合阿糖胞苷)和MA(米托蒽醌联合阿糖胞苷)治疗,以巩固化疗的两个疗程,随后定期接受亚砷酸化疗。随访22个月后,采用合适的治疗方案观察到持续的骨髓缓解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号